White Paper

Preparing for the ’Green Wave’ of Medical Cannabis in Workers’ Comp Claims

EK Health’s Chief Medical Officer shares what he found on his education journey to better understand medical cannabis in the workers’ comp space.

White Paper Summary

It takes a true thought leader to be three years ahead of one of the most significant developments in an industry as complex as workers’ compensation.

Early in 2018, EK Health’s Chief Medical Officer and Medical Director Dr. Douglas Benner M.D., MS, F.A.C.O.E.M, was invited to participate in a national conference panel on the topic of medical cannabis in workers’ comp claims, specifically addressing the legislative landscape, state-specific legal developments/exposure, medical/claim implications, trends and the future impact on the workers’ comp industry.

To prepare, he conducted a crash review of what was scientifically known and accepted on the medical uses of the cannabis plant at the time.

In 2018, the topic was not yet on the radar for most companies in the managed care space, as only one or two states were requiring employers and workers’ compensation carriers to pay for medical cannabis. Today, medical cannabis has captured center stage in the workers’ compensation industry as more states move to legalize its use and more court cases have required paying for it.

The amount of clinical research being conducted is staggering.


To learn more about EK Health Services, visit ekhealth.com.

 

As a leading national managed care company, EK Health Services, Inc. sets the gold standard for medical case management, utilization review, medical bill review, network management, and Medicare Set-Asides. We facilitate quality, cost-efficient medical treatment for workers' compensation claims.

More from Risk & Insurance

More from Risk & Insurance

Risk Matrix: Presented by Liberty Mutual Insurance

10 Ways Professional Lines Are Facing Post Pandemic Risks

From securities litigation down to adoption of ESG efforts, how professional lines embrace the post-pandemic world will require an added review of potential risk.
By: | September 1, 2021




The R&I Editorial Team can be reached at [email protected]